Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms by Histologic Type

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,084 public trials 6,466 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Withdrawn

89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC

NCT05423197

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Stanford Cancer Institute San Francisco, California, United States

View Trial Details

Withdrawn

Pre-emptive Anakinra for Cytokine Event Reduction

NCT06703216

Conditions: B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR-T Cell Therapy, +24 more
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details

Withdrawn

A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia

NCT06903702

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Withdrawn

PDT Plus Vitamin D3 for Anal Dysplasia

NCT02698293

Conditions: Anal Dysplasia, Carcinoma, Carcinoma in Situ, +3 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details